Biotech Values

[DonkeyMan]

VKTX- i am surprised they haven’t been bought out yet. If an acquisition is desired by management and there are credible suitors, i think it would make sense for the acquiring company to do it prior to the design of the large phase 3 trial. Meeting with FDA on trial design i believe is at the end of the year.

Maybe the data released at obesity week provides the impetus for an acquisition to get done.

What do people think the bar is to be considered home run data?